Adriana Kahn, Assistant Professor of Medicine (Oncology) at Yale Cancer Center, shared the following post by Yale Cancer Center, on Twitter, adding the following:
“Happy to lead the joint effort from Yale Cancer Center, Yale Breast Cancer Research, and Foundation Medicine to better characterize genomic alterations from tumors from >2k patients with breast cancer subtypes stratified by ER and HER2 statuses”
Quoting Yale Cancer Center:
“Later today at San Antonio Breast Cancer Symposium, Adriana Kahn & Maryam Lustberg will present research showing key differences in the genetics of HER2-low advanced breast cancer, incl age & presence of hormone receptors.”
For details click here.
Source: Adriana Kahn/Twitter and Yale Cancer Center/Twitter